University of Arizona Cancer Center member Mark “Marty” Pagel, PhD, will receive a $2 million grant from the National Institutes of Health to study the effectiveness of personalized baking soda therapy to treat breast cancer.
The grant will be used to help refine a new magnetic resonance imaging method for measuring pH, or acid content, of a tumor that has been discovered in a patient but not yet treated. By measuring the acid content of the tumor, doctors can monitor the effectiveness of personalized treatments such as baking soda on both tumors and healthy tissue, and even predict the effectiveness of chemotherapies before the patient starts the medication.
Dr. Pagel, a member of the UACC’s Cancer Imaging program and an associate professor of biomedical engineering, has worked extensively on this research, collaborating with Ian Robey, assistant professor of research at the UACC, and clinical collaborators Alison Stopeck, MD, Setsuko Chambers, MD, and Phil Kuo, MD, PhD.
Dr. Pagel credits the Community Foundation of Southern Arizona and the Phoenix Friends of the Arizona Cancer Center with the generous gifts that allowed him and his team to lay the groundwork for the research that led to the NIH grant.
Read more about Dr. Pagel’s study at the University of Arizona College of Engineering website.
March 21, 2012